Platinum Sponsors

KMM Group

Spectrum Plastics

Steri-Tek


Silver Sponsors

Able Electropolishing

Able Medical Devices

Arthur G Russell

ATL

Beaumont

BihlerMed

Delmiaworks

Eldon James

Elmas Medical

Eurofins

Forefront

IRP Medical

J-Pac

Kistler

KP

MedBio

MICRO

MTD Micromolding

MW Medical Solutions


Supporting Organizations

EDC Utah

Governor's Office of Economic Development


Gold Sponsors

B Braun

Lumenous

Natech Plastics

Natvar

NDH Medical

Trademark Plastics


Silver Sponsors

Nelson Labs

Quality, Microbiology & Sterilization Services

RAUMEDIC

RJG

STI/McLean

Spectrum Solutions

Teleflex Medical OEM

Triangle

Vance Street Capital

Viant

Wytech


Bronze Sponsors

Magnum Medical

maxon

PMCF

Donna Bibber

Donna M. Bibber, Vice President of Business Development, Isometric Micro Molding Inc.
Donna Bibber has assisted in over 1,000 micro molding and assembly device programs. Her plastics engineering background, expertise, and unique problem-solving skills earned her an excellent reputation and is recognized nationally and internationally for her work in micro manufacturing. Bibber’s expertise in intraocular implants, bio-resorbable polymers, and PEEK implants gave rise to many new devices commercially available today. She is a member of the Society of Biomaterials and Society of Plastics Engineers. Bibber has also been a regular speaker at medical and drug delivery conferences and has published a number of technical papers on micro molding and micro assembly. She graduated with a BS in Plastics Engineering from University of Massachusetts—Lowell.

Tom Black

Tom Black, New Business Development Manager, Command Medical Products
Thomas Black is new business development manager at Command Medical Products. With more than 37 years of medical device industry experience, Black is responsible for the development of new contract manufacturing business for Command Medical. A graduate of the University of South Carolina and a veteran of the U.S. Air Force, Black is a frequent speaker at medical device conferences and a contributor to industry trade media.

Kelvyn H. Cullimore Jr.

Kelvyn H. Cullimore Jr., President and CEO, BioUtah
Kelvyn H. Cullimore Jr. was named president and CEO of BioUtah, the state trade association for life science companies in Utah, in October 2018. In that capacity, he also serves on the board of the World Trade Center Utah and on the advisory board of the Center for Medical Innovation at the University of Utah. From 1992 to 2018, Cullimore was the president and CEO of Dynatronics Corporation, a manufacturer of physical therapy devices and products. Dynatronics is a publicly traded company, originally founded by Cullimore and his father in 1979. From 2003 to 2015, Cullimore served on the Board of Directors of the Medical Device Manufacturers Association headquartered in Washington, D.C. He is a past Trustee of the Utah Technology Council, an industry association which, at the time, included life science and high-tech companies. Cullimore was also the first mayor of Cottonwood Heights, Utah—a suburb of Salt Lake City—from 2005-2018.

Dr. Michael Drues

Michael Drues, Ph.D., President, Vascular Sciences
Michael Drues, Ph.D., is president of Vascular Sciences, an education, training, and consulting company offering a broad range of services to medical device, pharmaceutical, and biotechnology companies including stimulating and innovative educational programing, creative regulatory strategy and completive regulatory intelligence, regulatory submission design, FDA presentation preparation and defense, brainstorming sessions, prototype design, product development, benchtop and animal testing, clinical trial design, reimbursement, clinical acceptance, business development, and technology assessment. Dr. Drues received his B.S., M.S., and Ph.D. degrees in Biomedical Engineering from Iowa State University in Ames, Iowa. He has worked for and consulted with leading medical device, pharmaceutical, and biotechnology companies ranging in size from start-ups to Fortune 100 companies. He also works on a regular basis for the U.S. Food and Drug Administration (FDA), Health Canada, the U.S. and European Patent Offices, the Centers for Medicare and Medicaid Services (CMS), and other regulatory and governmental agencies around the world.

Ben Dunn

Ben Dunn, Managing Director, Covington Associates
Ben Dunn is a managing director with the healthcare investment banking firm Covington Associates. Specializing in medical technology businesses, he has orchestrated over 100 transactions (including over 50 medical outsourcing deals), and has been one of the most active bankers in this sector. Having represented and consummated deals with clients from Asia, Europe, and North America, Dunn understands the global nature of medical technology. He is a frequent speaker at healthcare conferences and author of numerous articles.

Jim Fitzgerald

Jim Fitzgerald, CEO, Flexan
Jim Fitzgerald joined Flexan in June 2015. He says, “Leading an organization like Flexan provides me with the unique opportunity to not only support market leading companies from across the globe in their efforts to produce transformative products, but to work alongside a group of talented and dedicated team members who embrace their role in making our company successful through the successes of our customers.” He began his career with Baxter and Cardinal Health where he served a combined 16 years in sales and general management roles. From Cardinal Health, Fitzgerald joined Vesta Inc. as an executive vice president responsible for sales, marketing, and business development. Most recently, he served as the chief operating officer at The Institute for Transfusion Medicine. Fitzgerald holds a Bachelor of Business Administration from the University of Notre Dame and a Master of Business Administration from the Kellogg School of Management at Northwestern University.

Tony Freeman

Anthony S. Freeman, President, A.S. Freeman Advisors LLC
Tony Freeman leads A. S. Freeman Advisors, a transaction advisory firm focused on the precision manufacturing and specialty materials industries. With a focus on supply chain companies, Freeman Advisors offers buy-side and sell-side services as well as strategic consulting on market selection and value enhancement. Clients range from Fortune 500 firms to small, privately held companies in the life sciences, aerospace, electronics, and specialty chemical industries. Freeman also serves as executive director of mdmX, an industry organization for medical supply chain executives. He is a regular contributor to MPO and other industry publications. He holds a BA from the University of Chicago and an MBA from Columbia University.

David Mabie

David Mabie, President, CincyMED
Dave Mabie started his thirty-year career in the life sciences industry in technical sales of medical raw materials, later moving into program management, marketing, and director roles for injection molded components and manufacturing of Class ll and Class lll disposable medical devices. From 2006 to 2019, he served as vice president, business development for outsourced manufacturers ATEK Medical (exited to VENTION Medical 2011), followed by Providien (exited to Carlisle CIT 2019) where he assisted the world’s leading medical device companies by shifting manufacturing within the US and to Costa Rica and Mexico for improved quality, lower cost of manufacturing, and supply chain consolidation. To meet demand during his time at ATEK, the company expanded capacity by adding one new manufacturing facility in the United States and two in Costa Rica. In 2010, ATEK was named by Inc. Magazine as a U.S. Top 500 growth company. Mabie is currently an Editorial Advisory Board member for Medical Product Outsourcing magazine. He routinely serves as advisor to leading investment banking and private equity firms looking to establish or grow their investment platforms within the medical device contract manufacturing space, and has served as senior advisor to FOXCONN Medical, a division of FOXCONN—the world’s largest electro-mechanical services provider.

Adeeb Mahmud

Adeeb Mahmud, Managing Director, FSG
Adeeb Mahmud is a managing director at FSG, where he leads projects on corporate social impact, global development, and philanthropy. He joined FSG in 2006, is a member of the firm’s leadership team, and also leads FSG’s Washington, D.C. office. He brings 15 years of experience in private sector consulting and global development. Mahmud has led corporate philanthropy, corporate responsibility, and shared value engagements with companies across industries, including Abbott, Sanofi, Merck, Novo Nordisk, Mastercard, and Dow Chemical. As part of these and other projects, Adeeb has conducted field-work in Brazil, Ethiopia, India, Israel, Mexico, Nigeria, Rwanda, Saudi Arabia, South Africa, and Uganda. Other engagements include advising USAID-funded collective impact efforts in Uganda and Cambodia, developing shared value corporate partnership opportunities for Save the Children USA, and identifying ways to accelerate access for drugs, diagnostics, and vaccines on behalf of the Bill & Melinda Gates Foundation. Before FSG, Mahmud worked in business development of a start-up biotechnology company in Boston. Previously, he was a management consultant working with global healthcare clients. Mahmud holds a Master’s in public policy from Harvard University’s John F. Kennedy School of Government, where he was selected as a Reynolds Fellow for social entrepreneurship, and a Bachelor’s, cum laude, from Middlebury College.

Bryan R. McRae, MD

Bryan R. McRae, MD, Executive Director (Interim), Center for Medical Innovation (CMI); Assistant Professor, Otolaryngology—Head & Neck Surgery (ENT), University of Utah School of Medicine
Dr. Bryan R. McRae is a practicing surgeon at the University of Utah and also serves as interim executive director of the Center for Medical Innovation (CMI). CMI provides medical device development support for educational programs, including the annual “Bench to Bedside” competition, as well as support for faculty projects focused on innovative new medical devices or software technologies. Dr. McRae holds multiple patents (provisional and utility submissions) for various surgical devices and works regularly with the U’s Biomedical Engineering students on device development projects.

Nick Packet

Nick Packet, Medical and Pharmaceutical Tyvek® Packaging—East Coast MDM Specialist, Dupont
Nick Packet has 17 years of medical device packaging experience. He joined the DuPont™ Tyvek® Healthcare team in 2017, where he supports medical device companies in their development and qualification of sterile packaging systems. With a broad perspective of the market, Packet provides technical support and insights around packaging trends, as well as works with MDMs to better understand the total lifecycle of their products and how packaging can play a positive role. The DuPont™ Tyvek® Healthcare group is a member of the Healthcare Plastics Recycling Council (HPRC), of which Packet (with a strong interest in sustainability) is an active participant. He supported the Flexible Packaging Recycling Study and, most recently, lead a project team exploring advanced recycling processes and their ability to handle healthcare plastics. In supporting these different programs, he’s had the opportunity to present at the 2019 HealthPack conference and MDM West event, as well as participate in panel discussions at the Re|focus conference. Packet strives to learn how MDMs view and approach sustainability in their packaging designs and how these decisions play a part in the sustainability of the entire packaging system, and, ultimately, influence how a package is handled at its end of life.

Dr. Bryce Rutter

Bryce G. Rutter Ph.D., Founder and CEO, Metaphase Design Group Inc.
Dr. Bryce Rutter, founder and CEO of Metaphase Design Group Inc., is a leading expert in the research, ergonomics, and design of medical products and a worldwide specialist in hand-intensive products and packaging. His work includes collaborations with numerous global prestigious brands and high-profile start-ups on products ranging from robotic surgical systems, powered and manual instrument design, and drug delivery systems to disposables, mobile and wearable devices, to personal care products, IFUs, and usability and contextual inquiry research programs. Metaphase delivers innovative designs that redefine industry standards, invigorate sleepy brands, and create new product categories. Under Dr. Rutter’s leadership, Metaphase has received more than 120 international design excellence awards and 117 patents. Dr. Rutter holds degrees in industrial design and a Ph.D. in kinesiology, specializing in hand function.

Dr. Derek Sakata

Derek Sakata, MD, Professor and Vice Chair, Department of Anesthesiology, University of Utah
Derek Sakata is professor and vice chair in the Department of Anesthesiology at the University of Utah. Additionally, he serves as chief value officer and holds adjunct appointments of Bioengineering and Ophthalmology. He is also the founding and current chair for the Faculty Innovation Research Entrepreneur (FIRE) Scholars in the Center for Medical Innovation. On the hospital side, he is the executive medical director for Ambulatory Services and the medical director for Specialty Clinics for the University of Utah’s Southern Service Area. He has contributed to his field through co-inventing two medical devices that are currently on the market from two different startup companies. These devices are in use in approximately 1,000 healthcare facilities in the United States and approximately 23 countries. He enjoys spending time with his wife and two young sons.

Maria Shepherd

Maria Shepherd, President and CEO, Medi-Vantage
Maria Shepherd launched Medi-Vantage in 2007 with the goal to help her medical device clients grow profitably by applying her strategic expertise in the marketing, commercialization, and product development of medical devices. Since then, Medi- Vantage has worked with over 250 medical device companies performing strategy research to support (or decline) acquisitions, determine pricing strategy, commercialize disruptive new medical device technologies, or assist product development teams in the design or re-engineering of medical devices. Prior to launching Medi-Vantage, Shepherd developed her experience in the medical device industry as a business leader in a variety of large and start-up organizations. In her last industry role, she was vice president of marketing for Oridion, a start-up company acquired by Medtronic. Shepherd also served as director of marketing for Philips, serving the critical care patient monitoring division in new technology development and acquisitions and at Boston Scientific in senior management roles. Maria has direct industry experience as a subject matter expert in 12 medical specialties. In addition to leading her team at Medi-Vantage, she serves on the board of MedExecWomen, with responsibility for its P&L. MedExecWomen is an organization focused on empowering female medtech executives to accelerate the positive impact of medical devices, diagnostics, drug delivery, and digital healthcare around the world. Shepherd holds a Master of Business Administration degree from Babson College, magna cum laude, and Bachelor of Arts in biology from the University of Pennsylvania.